SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 80 filers reported holding SERES THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 0.27 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $661,000 | -18.1% | 66,747 | +1.6% | 0.00% | 0.0% |
Q3 2016 | $807,000 | -59.5% | 65,680 | -4.3% | 0.00% | -66.7% |
Q2 2016 | $1,994,000 | +50.4% | 68,652 | +37.5% | 0.00% | +50.0% |
Q1 2016 | $1,326,000 | -23.5% | 49,916 | +1.0% | 0.00% | 0.0% |
Q4 2015 | $1,733,000 | +20.4% | 49,398 | +1.8% | 0.00% | 0.0% |
Q3 2015 | $1,439,000 | +70.9% | 48,536 | +139.1% | 0.00% | +100.0% |
Q2 2015 | $842,000 | – | 20,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Pioneering Inc. | 23,117,045 | $148,411,000 | 6.25% |
Eversept Partners, LP | 1,935,825 | $12,427,997 | 1.08% |
Kynam Capital Management, LP | 772,820 | $4,962,000 | 1.05% |
SILVERARC CAPITAL MANAGEMENT, LLC | 366,493 | $2,353,000 | 0.80% |
Lion Point Capital, LP | 626,803 | $3,228,000 | 0.71% |
FEDERATED HERMES, INC. | 18,499,136 | $118,765,000 | 0.35% |
Knott David M Jr | 110,000 | $706,000 | 0.30% |
Atom Investors LP | 108,820 | $699,000 | 0.25% |
Ikarian Capital, LLC | 131,310 | $843,000 | 0.17% |
HARVARD MANAGEMENT CO INC | 131,847 | $846,000 | 0.10% |